Skip to main content
Erschienen in: Head and Neck Pathology 3/2008

01.09.2008 | Original Paper

Human Kallikrein 8 Expression in Salivary Gland Tumors

verfasst von: Mark R. Darling, Sam Tsai, Linda Jackson-Boeters, Thomas D. Daley, Eleftherios P. Diamandis

Erschienen in: Head and Neck Pathology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

The human kallikrein 8 protein (KLK8) is expressed in many normal tissues including esophagus, skin, testis, tonsil, kidney, breast, and salivary gland, and is found in biological fluids including breast milk, amniotic fluid, seminal fluid and serum. It has also been shown to be a biomarker and prognostic factor for breast cancer. The aim of this study was to determine whether KLK8 is expressed in salivary gland tissues and salivary gland tumors (both benign and malignant), in order to compare normal with tumor tissues. Pleomorphic adenomas, adenoid cystic carcinomas, polymorphous low grade adenocarcinomas, acinic cell carcinomas, mucoepidermoid carcinomas, and adenocarcinomas NOS of both minor and major salivary glands were examined. The results of this study indicate that most salivary gland tumors show high levels of expression of KLK8.
Literatur
1.
Zurück zum Zitat Diamandis EP, Yousef GM, Luo LY. The human kallikrein gene family—implications in carcinogenesis. Trends Endocrinol Metab. 2000;11:54–60.PubMedCrossRef Diamandis EP, Yousef GM, Luo LY. The human kallikrein gene family—implications in carcinogenesis. Trends Endocrinol Metab. 2000;11:54–60.PubMedCrossRef
2.
Zurück zum Zitat Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: structure, function and association to disease. Endocr Rev. 2001;22:184–204.PubMedCrossRef Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: structure, function and association to disease. Endocr Rev. 2001;22:184–204.PubMedCrossRef
3.
Zurück zum Zitat Borgono CA, Michael IP, Diamandis EP. Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res. 2004;2:257–80.PubMed Borgono CA, Michael IP, Diamandis EP. Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res. 2004;2:257–80.PubMed
4.
Zurück zum Zitat Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer. 2004;4:876–90.PubMedCrossRef Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer. 2004;4:876–90.PubMedCrossRef
5.
Zurück zum Zitat Yousef GM, Diamandis EP. Human tissue kallikreins: a new enzymatic cascade pathway? Biol Chem. 2002;383:1045–57.PubMedCrossRef Yousef GM, Diamandis EP. Human tissue kallikreins: a new enzymatic cascade pathway? Biol Chem. 2002;383:1045–57.PubMedCrossRef
6.
Zurück zum Zitat Rajapakse S, Ogiwara K, Takano N, et al. Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins. FEBS Lett. 2005;579:6879–84.PubMedCrossRef Rajapakse S, Ogiwara K, Takano N, et al. Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins. FEBS Lett. 2005;579:6879–84.PubMedCrossRef
7.
Zurück zum Zitat Diamandis EP, Yousef GM. Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem. 2002;48:1198–1205.PubMed Diamandis EP, Yousef GM. Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem. 2002;48:1198–1205.PubMed
8.
Zurück zum Zitat Diamandis EP, Yousef GM. Human tissue kallikrein gene family: a rich source of novel disease biomarkers. Expert Rev Mol Diagn. 2001;1:182–90.PubMedCrossRef Diamandis EP, Yousef GM. Human tissue kallikrein gene family: a rich source of novel disease biomarkers. Expert Rev Mol Diagn. 2001;1:182–90.PubMedCrossRef
9.
Zurück zum Zitat Obiezu C, Diamandis E. Human tissue kallikrein family: applications in cancer. Cancer Lett. 2005;224:1–22.PubMed Obiezu C, Diamandis E. Human tissue kallikrein family: applications in cancer. Cancer Lett. 2005;224:1–22.PubMed
10.
Zurück zum Zitat Petraki CD, Papanastasiou PA, Karavana VN, et al. Cellular distribution of human tissue kallikreins: immunohistochemical localization. Biol Chem. 387;2006:653–63.PubMedCrossRef Petraki CD, Papanastasiou PA, Karavana VN, et al. Cellular distribution of human tissue kallikreins: immunohistochemical localization. Biol Chem. 387;2006:653–63.PubMedCrossRef
11.
Zurück zum Zitat Yoshida S, Taniguchi M, Hirata A, et al. Sequence analysis and expression of human neuropsin cDNA and gene. Gene. 1998;213:9–16.PubMedCrossRef Yoshida S, Taniguchi M, Hirata A, et al. Sequence analysis and expression of human neuropsin cDNA and gene. Gene. 1998;213:9–16.PubMedCrossRef
12.
Zurück zum Zitat Kishi T, Grass L, Soosaipillai A, et al. Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids. Clin Chem. 2003;49:87–96.PubMedCrossRef Kishi T, Grass L, Soosaipillai A, et al. Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids. Clin Chem. 2003;49:87–96.PubMedCrossRef
13.
Zurück zum Zitat Ellis GL, Auclair PL. Tumors of the salivary glands. In: Rosai J, Sobin LH, editors. Atlas of tumor pathology, Third Series, Fascicle 17. Washington, D.C.: Armed Forces Institute of Pathology; 1996. p. 39–56, 155–228. Ellis GL, Auclair PL. Tumors of the salivary glands. In: Rosai J, Sobin LH, editors. Atlas of tumor pathology, Third Series, Fascicle 17. Washington, D.C.: Armed Forces Institute of Pathology; 1996. p. 39–56, 155–228.
14.
Zurück zum Zitat Black MH, Magklara A, Obiezu CV, et al. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen. Clin Chem. 1999;45:790–9.PubMed Black MH, Magklara A, Obiezu CV, et al. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen. Clin Chem. 1999;45:790–9.PubMed
15.
Zurück zum Zitat Allred DC, Clark GM, Elledge R, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst. 1993;85:200–6.PubMedCrossRef Allred DC, Clark GM, Elledge R, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst. 1993;85:200–6.PubMedCrossRef
16.
Zurück zum Zitat Tuck AB, O’Malley FP, Singhal H, et al. Osteopontin expression in a group of lymph node negative breast cancer patients. Int J Cancer. 1998;79:502–8.PubMedCrossRef Tuck AB, O’Malley FP, Singhal H, et al. Osteopontin expression in a group of lymph node negative breast cancer patients. Int J Cancer. 1998;79:502–8.PubMedCrossRef
17.
Zurück zum Zitat Kishi T, Grass L, Soosaipillai A, et al. Human kallikrein 8, a novel biomarker for ovarian carcinoma. Cancer Res. 2003;63:2771–4.PubMed Kishi T, Grass L, Soosaipillai A, et al. Human kallikrein 8, a novel biomarker for ovarian carcinoma. Cancer Res. 2003;63:2771–4.PubMed
18.
Zurück zum Zitat Yousef GM, Polymeris ME, Yacoub GM, et al. Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res. 2003;63:2223–7.PubMed Yousef GM, Polymeris ME, Yacoub GM, et al. Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res. 2003;63:2223–7.PubMed
19.
Zurück zum Zitat Magklara A, Scorilas A, Katsaros D, et al. The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin Cancer Res. 2001;7:806–11.PubMed Magklara A, Scorilas A, Katsaros D, et al. The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin Cancer Res. 2001;7:806–11.PubMed
20.
Zurück zum Zitat Shigemasa K, Tian X, Gu L, et al. Human kallikrein 8 (KLK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer. Oncol Rep. 2004;11:1153–9.PubMed Shigemasa K, Tian X, Gu L, et al. Human kallikrein 8 (KLK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer. Oncol Rep. 2004;11:1153–9.PubMed
21.
Zurück zum Zitat Borgono CA, Kishi T, Scorilas A, et al. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer. Clin Cancer Res. 2006;12:1487–93.PubMedCrossRef Borgono CA, Kishi T, Scorilas A, et al. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer. Clin Cancer Res. 2006;12:1487–93.PubMedCrossRef
22.
Zurück zum Zitat Yousef GM, Yacoub GM, Polymeris ME, et al. Kallikrein gene downregulation in breast cancer. Br J Cancer. 2004;90:167–72.PubMedCrossRef Yousef GM, Yacoub GM, Polymeris ME, et al. Kallikrein gene downregulation in breast cancer. Br J Cancer. 2004;90:167–72.PubMedCrossRef
23.
Zurück zum Zitat Paliouras M, Diamandis EP. Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines. Breast Cancer Res Treat. 2007;102:7–18.PubMedCrossRef Paliouras M, Diamandis EP. Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines. Breast Cancer Res Treat. 2007;102:7–18.PubMedCrossRef
24.
Zurück zum Zitat Cané S, Bignotti E, Bellone S, et al. The novel serine protease tumor-associated differentially expressed gene-14(KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer. Am J Obstet Gynecol. 2004;190:60–6.PubMedCrossRef Cané S, Bignotti E, Bellone S, et al. The novel serine protease tumor-associated differentially expressed gene-14(KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer. Am J Obstet Gynecol. 2004;190:60–6.PubMedCrossRef
25.
Zurück zum Zitat Jin H, Nagai N, Shigemasa K, et al. Expression of tumor-associated differentially expressed Gene-14 (TADG-14/KLK8) and its protein KLK8 in uterine endometria and endometrial carcinomas. Tumour Biol. 2006;27:274–82.PubMedCrossRef Jin H, Nagai N, Shigemasa K, et al. Expression of tumor-associated differentially expressed Gene-14 (TADG-14/KLK8) and its protein KLK8 in uterine endometria and endometrial carcinomas. Tumour Biol. 2006;27:274–82.PubMedCrossRef
26.
Zurück zum Zitat Sher YP, Chou CC, Chou RH, et al. Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness. Cancer Res. 2006;66:11763–70.PubMedCrossRef Sher YP, Chou CC, Chou RH, et al. Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness. Cancer Res. 2006;66:11763–70.PubMedCrossRef
27.
Zurück zum Zitat Kishi T, Cloutier SM, Kundig C, et al. Activation and enzymatic characterization of recombinant human kallikrein 8. Biol Chem. 2006;387:723–31.PubMedCrossRef Kishi T, Cloutier SM, Kundig C, et al. Activation and enzymatic characterization of recombinant human kallikrein 8. Biol Chem. 2006;387:723–31.PubMedCrossRef
28.
Zurück zum Zitat Pampalakis G, Sotiropoulou G. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. Biochim Biophys Acta. 2007;1776:22–31.PubMed Pampalakis G, Sotiropoulou G. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. Biochim Biophys Acta. 2007;1776:22–31.PubMed
29.
Zurück zum Zitat Emami N, Diamandis EP. Human tissue kallikreins: a road under construction. Clin Chim Acta. 2007;381:78–84.PubMedCrossRef Emami N, Diamandis EP. Human tissue kallikreins: a road under construction. Clin Chim Acta. 2007;381:78–84.PubMedCrossRef
30.
Zurück zum Zitat Yoon H, Laxmikanthan G, Lee J, et al. Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J Biol Chem. 2007;282:31852–64.PubMedCrossRef Yoon H, Laxmikanthan G, Lee J, et al. Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J Biol Chem. 2007;282:31852–64.PubMedCrossRef
31.
Zurück zum Zitat Darling MR, Jackson-Boeters L, Daley TD, et al. Human kallikrein 6 expression in salivary gland tumors. J Histochem Cytochem. 2006;54:337–42.PubMedCrossRef Darling MR, Jackson-Boeters L, Daley TD, et al. Human kallikrein 6 expression in salivary gland tumors. J Histochem Cytochem. 2006;54:337–42.PubMedCrossRef
32.
Zurück zum Zitat Darling MR, Jackson-Boeters L, Daley TD, et al. Human kallikrein 13 expression in salivary gland tumors. Int J Biol Markers. 2006;21:106–10.PubMed Darling MR, Jackson-Boeters L, Daley TD, et al. Human kallikrein 13 expression in salivary gland tumors. Int J Biol Markers. 2006;21:106–10.PubMed
33.
Zurück zum Zitat Darling MR, Tsai S, Jackson-Boeters L, et al. Human kallikrein 3 (prostate specific antigen) and human kallikrein 5 expression in salivary gland tumors. Int J Biol Markers. 2006;21:201–5.PubMed Darling MR, Tsai S, Jackson-Boeters L, et al. Human kallikrein 3 (prostate specific antigen) and human kallikrein 5 expression in salivary gland tumors. Int J Biol Markers. 2006;21:201–5.PubMed
34.
Zurück zum Zitat Paliouras M, Diamandis EP. The kallikrein world: an update on the human tissue kallikreins. Biol Chem 2006;387:643–52.PubMedCrossRef Paliouras M, Diamandis EP. The kallikrein world: an update on the human tissue kallikreins. Biol Chem 2006;387:643–52.PubMedCrossRef
Metadaten
Titel
Human Kallikrein 8 Expression in Salivary Gland Tumors
verfasst von
Mark R. Darling
Sam Tsai
Linda Jackson-Boeters
Thomas D. Daley
Eleftherios P. Diamandis
Publikationsdatum
01.09.2008
Verlag
Humana Press Inc
Erschienen in
Head and Neck Pathology / Ausgabe 3/2008
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-008-0068-z

Weitere Artikel der Ausgabe 3/2008

Head and Neck Pathology 3/2008 Zur Ausgabe

Sine qua none Radiology-Pathology

Bilateral Warthin Tumors of the Parotid Gland

Neu im Fachgebiet Pathologie